| __timestamp | AbbVie Inc. | Bristol-Myers Squibb Company |
|---|---|---|
| Wednesday, January 1, 2014 | 3297000000 | 4534000000 |
| Thursday, January 1, 2015 | 4285000000 | 5920000000 |
| Friday, January 1, 2016 | 4366000000 | 4940000000 |
| Sunday, January 1, 2017 | 4982000000 | 6411000000 |
| Monday, January 1, 2018 | 10329000000 | 6345000000 |
| Tuesday, January 1, 2019 | 6407000000 | 6148000000 |
| Wednesday, January 1, 2020 | 6557000000 | 11143000000 |
| Friday, January 1, 2021 | 7084000000 | 10195000000 |
| Saturday, January 1, 2022 | 6510000000 | 9509000000 |
| Sunday, January 1, 2023 | 8453000000 | 9299000000 |
| Monday, January 1, 2024 | 12791000000 | 11159000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, innovation is key. Over the past decade, AbbVie Inc. and Bristol-Myers Squibb Company have been at the forefront of this race, investing heavily in research and development (R&D). From 2014 to 2023, Bristol-Myers Squibb consistently outpaced AbbVie in R&D spending, with an average annual investment of approximately $7.4 billion compared to AbbVie's $6.2 billion. Notably, in 2020, Bristol-Myers Squibb's R&D expenses peaked at over $11 billion, a 70% increase from 2014, highlighting their commitment to innovation. Meanwhile, AbbVie made a significant leap in 2018, doubling its R&D investment to over $10 billion, showcasing its strategic focus on groundbreaking therapies. As these giants continue to push the boundaries of medical science, their investments underscore the critical role of R&D in driving pharmaceutical advancements.
Who Generates More Revenue? AbbVie Inc. or Bristol-Myers Squibb Company
Who Prioritizes Innovation? R&D Spending Compared for AbbVie Inc. and Zoetis Inc.
R&D Spending Showdown: AbbVie Inc. vs Vericel Corporation
Research and Development Investment: AbbVie Inc. vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.